ResMed (RMD)
(Delayed Data from NYSE)
$244.94 USD
+1.96 (0.81%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $244.75 -0.19 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/24/24 |
---|---|
Current Quarter | 2.02 |
EPS Last Quarter | 2.08 |
Last EPS Surprise | 2.46% |
ABR | 2.33 |
Earnings ESP
|
-0.12% |
---|---|
Current Year | 8.92 |
Next Year | 9.66 |
EPS (TTM) | 7.73 |
P/E (F1) | 27.47 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (6/2025) |
Next Year (6/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.19B | 1.25B | 5.03B | 5.35B |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 1.23B | 1.26B | 5.09B | 5.49B |
Low Estimate | 1.17B | 1.24B | 5.00B | 5.21B |
Year ago Sales | 1.10B | 1.16B | 4.69B | 5.03B |
Year over Year Growth Est. | 7.95% | 7.29% | 7.37% | 6.32% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (6/2025) |
Next Year (6/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.02 | 2.21 | 8.92 | 9.66 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | 2.02 | 2.19 | 8.72 | 9.29 |
High Estimate | 2.08 | 2.26 | 9.09 | 10.23 |
Low Estimate | 1.95 | 2.17 | 8.69 | 9.29 |
Year ago EPS | 1.64 | 1.88 | 7.72 | 8.92 |
Year over Year Growth Est. | 23.17% | 17.55% | 15.54% | 8.34% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (6/2025) |
Next Year (6/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (6/2025) |
Next Year (6/2026) |
|
---|---|---|---|---|
Current | 2.02 | 2.21 | 8.92 | 9.66 |
7 Days Ago | 2.02 | 2.21 | 8.92 | 9.66 |
30 Days Ago | 2.01 | 2.19 | 8.72 | 9.60 |
60 Days Ago | 2.04 | 2.17 | 8.72 | 9.57 |
90 Days Ago | 2.04 | 2.17 | 8.72 | 9.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (6/2025) |
Next Year (6/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.02 | 2.19 | 8.89 | 9.29 |
Zacks Consensus Estimate | 2.02 | 2.21 | 8.92 | 9.66 |
Earnings ESP | -0.12% | -0.79% | -0.37% | -3.85% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.08 | 2.13 | 1.88 | 1.64 | NA |
Estimate | 2.03 | 1.92 | 1.81 | 1.63 | NA |
Difference | 0.05 | 0.21 | 0.07 | 0.01 | 0.09 |
Surprise | 2.46% | 10.94% | 3.87% | 0.61% | 4.47% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more